ERBB2 and breast carcinoma: Analysis of the Metabric dataset obtained from 1986 specimens [20] also identified a significant decrease in NR4A1 mRNA expression in luminal A/B, HER2-positive and basal-like breast cancers when compared with normal breast tissues (Figure 1B).